Rafina Innovations Inc. (VICA)
Rafina Innovations Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Glasgow, NI, GB. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $14,572. On trailing twelve-month figures it carries a trailing P/E of -0.09, a net margin of -26.9%. Its beta of 9.70 implies it has historically moved more than the broad market.
Rafina Innovations Inc. is a company that develops, researches, commercializes, and markets medical technologies. Its operations are divided into two main areas: its Clinic division and its Technology division. The company manages specialized rehabilitation clinics for prosthetics, orthotics, and comprehensive diabetic foot care, serving patients in Southern Europe, the Middle East, and North Africa. Within its Technology arm, Rafina Innovations Inc. is actively engaged in the creation, development, and market introduction of medical devices, innovative methods, and products. This work covers a broad range of fields, including but not limited to, prosthetics, orthotics, general rehabilitation, bioengineering, mobility, diabetes and diabetic foot care, tissue mechanics, ultrasonics, medical signal processing and analysis, general medical technology, orthopedics, and robotic surgery. Additionally, the company licenses its proprietary technological advancements. Founded in 2007, the company changed its name from HCi Viocare to Rafina Innovations Inc. in July 2018. Its base of operations is in Glasgow, United Kingdom.
Rafina Innovations Inc. is most often compared with the following Healthcare names: